Portfolio company
Partillion Bioscience
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops nanovial reagent platforms for single-cell analysis and cell-cell interaction studies for biopharmaceutical researchers and academic scientists.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Partillion Bio
This company produces nanovial reagent kits for single-cell analysis and sorting, serving pharmaceutical, biotechnology and academic research laboratories.
Lightcast Bio
This company develops a microfluidic platform for single-cell functional analysis for pharmaceutical companies and academic research institutions.
Atrandi Biosciences
This company develops single-cell analysis platforms and microfluidic technologies for life science researchers in genomics, screening and biological innovation.
Mission Bio
This company develops single-cell multi-omics analysis platforms for researchers and clinicians to enable precision medicine and drug development.
Cellanome
This company develops a multi-omics platform that integrates imaging and sequencing for single-cell analysis to serve biotechnology researchers and drug developers.
LevitasBio
This company develops cellular analysis platforms and sample preparation kits for researchers in the life sciences, pharmaceutical development, and diagnostic sectors.
Abiosciences
This company provides single-cell genomics and bioinformatics platforms to pharmaceutical companies and researchers for drug target and biomarker discovery.
Zephyrus Biosciences
This company develops single-cell protein analysis instruments and research tools for academic, biopharmaceutical and clinical scientists conducting disease research.
